ArticleCellular oncology (Dordrecht, Netherlands)2017

Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.

Diana Matias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.